The intent of this site to assist people with health issues that are, or could be, microbiome connected. There are MANY conditions known to have the severity being a function of the microbiome dysfunction, including Autism, Alzheimer’s, Anxiety and Depression. See this list of studies from the US National Library of Medicine. Individual symptoms like brain fog, anxiety and depression have strong statistical association to the microbiome. A few of them are listed here.
The base rule of the site is to avoid speculation, keep to facts from published studies and to facts from statistical analysis(with the source data available for those wish to replicate the results). Internet hearsay is avoid like the plague it is.
This document presents the results of statistical analysis on symptoms from viable, self-annotated Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?.
Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).
The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale.
Significance
Genus
p < 0.01
177
p < 0.001
160
p < 0.0001
138
p < 0.00001
124
Averages and Medians
I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at Faecalibacterium prausnitzii is below, we see that the average is above and the median below.
If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports).
tax_name
Rank
Symptom Avarage
Reference Average
Symptom Median
Reference Median
Faecalibacterium prausnitzii
species
10.366
12.277
11.415
9.08
Faecalibacterium
genus
10.881
12.843
12.131
9.826
Lachnospira
genus
2.401
2.738
1.9
1.418
Coprococcus
genus
1.071
1.443
0.737
0.428
Phocaeicola dorei
species
2.699
2.916
0.418
0.128
Parabacteroides
genus
2.385
2.634
1.724
1.989
Clostridium
genus
2.005
1.854
1.359
1.6
Roseburia faecis
species
0.951
1.215
0.576
0.457
Bacteroides caccae
species
1.59
0.852
0.286
0.402
Mediterraneibacter
genus
0.805
0.713
0.277
0.381
Bacteroides thetaiotaomicron
species
1.104
1.071
0.463
0.561
Lachnospira pectinoschiza
species
0.547
0.667
0.336
0.249
Bifidobacterium
genus
0.761
0.94
0.127
0.042
Bacteroides cellulosilyticus
species
1.396
0.836
0.076
0.151
Blautia wexlerae
species
0.869
0.569
0.314
0.386
Bilophila
genus
0.343
0.35
0.21
0.278
Anaerotruncus
genus
0.284
0.184
0.136
0.203
Akkermansia muciniphila
species
2.398
1.325
0.05
0.117
Akkermansia
genus
2.398
1.325
0.051
0.117
Anaerotruncus colihominis
species
0.259
0.173
0.133
0.198
Bacteria Incidence – How often is it reported
The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing. Look at Bacteroides uniformis below, we see that the average is above and the median below
tax_name
Rank
Incidence Odds Ratio
Chi2
Symptoms %
Reference %
Actinobacillus porcinus
species
0.61
6.9
24.5
40.2
Slackia faecicanis
species
1.53
7.8
44.8
29.2
Mogibacterium vescum
species
1.79
11.5
32.2
18
More or Less often based on Symptom Median All Incidence
This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.
Psychrobacter glacialis
species
0.002
0.37
30.5
664
247
Niabella
genus
0.002
0.39
27.4
583
226
Thermoanaerobacterium
genus
0.002
0.4
24.4
485
195
Chromatium
genus
0.002
0.41
24.2
508
206
Chromatium weissei
species
0.002
0.41
24.1
507
206
Thermoanaerobacterium islandicum
species
0.002
0.41
23.6
478
195
Syntrophomonas sapovorans
species
0.002
0.42
22.5
536
226
Sporosarcina pasteurii
species
0.002
0.42
21.9
440
184
Thermodesulfovibrio thiophilus
species
0.002
0.43
21
543
236
Sporosarcina
genus
0.002
0.43
20.6
444
191
Oenococcus
genus
0.002
0.45
20.1
609
272
Thermodesulfovibrio
genus
0.002
0.45
19.5
629
285
Helicobacter suncus
species
0.002
0.47
18.3
768
361
Desulfofundulus
genus
0.002
0.46
18.2
496
227
Herbaspirillum magnetovibrio
species
0.002
0.51
13.6
447
226
Streptococcus infantis
species
0.003
0.54
12
804
437
Sphingomonas
genus
0.002
0.53
11.9
457
242
Desulfotomaculum defluvii
species
0.003
0.56
11.3
1022
570
Alkalibacterium
genus
0.003
0.57
10.5
906
514
Hydrogenophilus
genus
0.003
0.58
10.2
1149
662
More or Less often based on Reference Median All Incidence
This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.
tax_name
Rank
Reference Median
Odds Ratio
Chi2
Below
Above
Methylonatrum
genus
0.005
0.35
374.2
1861
655
Methylonatrum kenyense
species
0.005
0.35
374.2
1861
655
Anaerotruncus colihominis
species
0.198
0.41
365.1
2712
1113
Anaerotruncus
genus
0.203
0.42
340.3
2688
1141
Odoribacter denticanis
species
0.006
0.41
291
1856
760
Luteolibacter
genus
0.017
0.38
245.6
1225
468
Luteolibacter algae
species
0.017
0.39
240.4
1214
468
Finegoldia
genus
0.0115
0.41
212.1
1210
501
Anaerococcus
genus
0.012
0.4
206.3
1099
444
Eggerthella sinensis
species
0.006
0.44
197.2
1289
568
Finegoldia magna
species
0.008
0.4
195.4
1014
408
Coprococcus
genus
0.4285
1.87
191.4
1379
2577
Desulfovibrio fairfieldensis
species
0.0395
0.4
175.1
868
347
Mogibacterium
genus
0.023
0.54
170.4
2154
1159
Bifidobacterium
genus
0.04245
1.8
169.2
1390
2505
Rubritalea
genus
0.004
0.43
168.7
969
415
Bifidobacterium longum
species
0.016
1.9
167.6
986
1876
Lysobacter
genus
0.004
0.36
164.9
657
236
Porphyromonas
genus
0.013
0.54
164.7
2156
1174
Psychrobacter glacialis
species
0.002
0.37
158
664
247
More or Less often based on Symptom Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
tax_name
Rank
Symptom Median Freq
Odds Ratio
Chi2
Below
Above
Clostridium taeniosporum
species
0.003
0.6
8.6
1359
821
More or Less often based on Reference Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
tax_name
Rank
Reference Median Freq
Odds Ratio
Chi2
Below
Above
Methylonatrum
genus
0.005
0.35
374.2
1861
655
Methylonatrum kenyense
species
0.005
0.35
374.2
1861
655
Anaerotruncus colihominis
species
0.198
0.41
365.1
2712
1113
Anaerotruncus
genus
0.203
0.42
340.3
2688
1141
Odoribacter denticanis
species
0.006
0.41
291
1856
760
Luteolibacter
genus
0.017
0.38
245.6
1225
468
Luteolibacter algae
species
0.017
0.39
240.4
1214
468
Finegoldia
genus
0.0115
0.41
212.1
1210
501
Anaerococcus
genus
0.012
0.4
206.3
1099
444
Eggerthella sinensis
species
0.006
0.44
197.2
1289
568
Finegoldia magna
species
0.008
0.4
195.4
1014
408
Coprococcus
genus
0.4285
1.87
191.4
1379
2577
Desulfovibrio fairfieldensis
species
0.0395
0.4
175.1
868
347
Mogibacterium
genus
0.023
0.54
170.4
2154
1159
Bifidobacterium
genus
0.04245
1.8
169.2
1390
2505
Rubritalea
genus
0.004
0.43
168.7
969
415
Bifidobacterium longum
species
0.016
1.9
167.6
986
1876
Lysobacter
genus
0.004
0.36
164.9
657
236
Porphyromonas
genus
0.013
0.54
164.7
2156
1174
Psychrobacter glacialis
species
0.002
0.37
158
664
247
Summary
A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.
A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.
Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.
Probiotics Suggestions
The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.
Good Count: Number of bacteria expected to shift in desired direction
Bad Count: Number of bacteria expected to shift in wrong direction
Impact: Estimator of impact based on Chi-2, Slope and R2 vectors
This document presents the results of statistical analysis on symptoms from viable, self-annotated Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?.
Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).
The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale.
Significance
Genus
p < 0.01
226
p < 0.001
199
p < 0.0001
176
p < 0.00001
157
Averages and Medians
I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at Bacteroides below, we see that the average is above and the median below.
If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports).
tax_name
Rank
Symptom Avarage
Reference Average
Symptom Median
Reference Median
Bacteroides
genus
28.633
25.842
24.114
27.576
Phocaeicola vulgatus
species
6.593
5.744
3.347
4.644
Phocaeicola
genus
11.777
10.78
9.291
10.397
Bacteroides uniformis
species
3.031
2.707
1.52
2.104
Parabacteroides
genus
2.552
2.631
1.714
2.058
Bacteroides thetaiotaomicron
species
1.27
1.056
0.455
0.678
Clostridium
genus
2.004
1.847
1.352
1.569
Oscillospira
genus
2.45
2.348
1.944
2.144
Bacteroides cellulosilyticus
species
1.032
0.84
0.07
0.237
Parabacteroides merdae
species
0.854
0.737
0.287
0.44
Coprococcus
genus
1.071
1.461
0.739
0.59
Pedobacter
genus
1.232
0.98
0.548
0.695
Novispirillum
genus
0.816
0.872
0.087
0.229
Insolitispirillum
genus
0.816
0.873
0.089
0.229
Insolitispirillum peregrinum
species
0.816
0.873
0.089
0.229
Bacteroides caccae
species
1.135
0.854
0.281
0.38
Bifidobacterium
genus
0.513
0.969
0.134
0.048
Bilophila
genus
0.395
0.347
0.206
0.276
Parabacteroides goldsteinii
species
0.565
0.571
0.13
0.194
Bilophila wadsworthia
species
0.376
0.339
0.197
0.256
Bacteria Incidence – How often is it reported
The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing. Look at Bacteroides uniformis below, we see that the average is above and the median below
tax_name
Rank
Incidence Odds Ratio
Chi2
Symptoms %
Reference %
Bifidobacterium catenulatum
species
0.69
8.3
25.2
36.2
Thiomonas thermosulfata
species
1.41
8
29.4
20.9
Aggregatibacter
genus
0.65
7.8
16
24.4
Desulfurispirillum
genus
1.45
8.4
25.5
17.5
Desulfurispirillum alkaliphilum
species
1.45
8.1
25.2
17.4
Actinobacillus pleuropneumoniae
species
0.6
8.4
11
18.5
Bifidobacterium cuniculi
species
0.62
7.8
12
19.3
Desulfonatronovibrio
genus
1.48
7.5
19.9
13.5
Erysipelothrix inopinata
species
1.47
7.4
19.9
13.5
Paraprevotella xylaniphila
species
1.6
9.2
16.6
10.4
Candidatus Phytoplasma phoenicium
species
1.59
8.7
16
10.1
Trichodesmium
genus
1.56
6.6
12.9
8.3
More or Less often based on Symptom Median All Incidence
This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.
tax_name
Rank
Symptom Median
Odds Ratio
Chi2
Below
Above
Alcanivorax
genus
0.002
0.26
75.2
375
98
Isoalcanivorax
genus
0.002
0.26
74.5
365
95
Isoalcanivorax indicus
species
0.002
0.26
74.5
365
95
Nostoc flagelliforme
species
0.002
0.27
67.3
316
84
Salidesulfovibrio
genus
0.002
0.3
63.2
381
115
Salidesulfovibrio brasiliensis
species
0.002
0.3
63.2
381
115
Niabella aurantiaca
species
0.002
0.34
62.1
524
176
Mycoplasmopsis lipophila
species
0.002
0.27
61.2
277
75
Psychroflexus
genus
0.002
0.3
60.4
348
105
Psychroflexus gondwanensis
species
0.002
0.3
60.4
348
105
Deferribacter autotrophicus
species
0.002
0.31
59.6
374
117
Pelagicoccus croceus
species
0.002
0.32
59.2
380
120
Deferribacter
genus
0.002
0.32
59
377
119
Psychrobacter glacialis
species
0.002
0.37
55.3
636
238
Thermodesulfatator atlanticus
species
0.002
0.3
53.6
276
83
Thermodesulfatator
genus
0.002
0.3
53.6
276
83
Segetibacter aerophilus
species
0.002
0.34
53.1
364
122
Bacillus ferrariarum
species
0.002
0.34
52.1
356
120
Niabella
genus
0.002
0.38
51.8
560
212
Rickettsia marmionii Stenos et al. 2005
species
0.002
0.35
51.6
379
131
More or Less often based on Reference Median All Incidence
This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.
tax_name
Rank
Reference Median
Odds Ratio
Chi2
Below
Above
Psychrobacter glacialis
species
0.002
0.37
150
636
238
Niabella aurantiaca
species
0.002
0.34
148.2
524
176
Desulfotomaculum
genus
0.004
0.51
147.5
1394
711
Alcanivorax
genus
0.002
0.26
145.8
375
98
Isoalcanivorax
genus
0.002
0.26
142.8
365
95
Isoalcanivorax indicus
species
0.002
0.26
142.8
365
95
Niabella
genus
0.002
0.38
132.4
560
212
Salidesulfovibrio
genus
0.002
0.3
127.5
381
115
Salidesulfovibrio brasiliensis
species
0.002
0.3
127.5
381
115
Bacteroides cellulosilyticus
species
0.237
0.59
127.2
2243
1325
Actinopolyspora
genus
0.002
0.38
125.5
524
198
Bifidobacterium
genus
0.048
1.68
125.3
1392
2332
Nostoc flagelliforme
species
0.002
0.27
122.8
316
84
Geobacillus
genus
0.003
0.43
122.4
672
291
Bacteroides heparinolyticus
species
0.003
0.49
122.1
928
454
Erysipelothrix muris
species
0.014
0.59
121.6
2029
1195
Pelagicoccus croceus
species
0.002
0.32
120.7
380
120
Deferribacter autotrophicus
species
0.002
0.31
120.3
374
117
Deferribacter
genus
0.002
0.32
119.9
377
119
Psychroflexus
genus
0.002
0.3
117.5
348
105
More or Less often based on Symptom Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
tax_name
Rank
Symptom Median Freq
Odds Ratio
Chi2
Below
Above
Clostridium taeniosporum
species
0.003
0.62
16
1295
805
Tetragenococcus doogicus
species
0.003
0.67
11.5
1316
881
Dethiosulfovibrio
genus
0.004
0.67
11.3
1457
981
Hydrocarboniphaga daqingensis
species
0.004
0.71
8.7
1549
1096
Mycoplasmopsis
genus
0.005
0.72
8
1709
1230
More or Less often based on Reference Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
tax_name
Rank
Reference Median Freq
Odds Ratio
Chi2
Below
Above
Psychrobacter glacialis
species
0.002
0.37
150
636
238
Niabella aurantiaca
species
0.002
0.34
148.2
524
176
Desulfotomaculum
genus
0.004
0.51
147.5
1394
711
Alcanivorax
genus
0.002
0.26
145.8
375
98
Isoalcanivorax
genus
0.002
0.26
142.8
365
95
Isoalcanivorax indicus
species
0.002
0.26
142.8
365
95
Niabella
genus
0.002
0.38
132.4
560
212
Salidesulfovibrio
genus
0.002
0.3
127.5
381
115
Salidesulfovibrio brasiliensis
species
0.002
0.3
127.5
381
115
Bacteroides cellulosilyticus
species
0.237
0.59
127.2
2243
1325
Actinopolyspora
genus
0.002
0.38
125.5
524
198
Bifidobacterium
genus
0.048
1.68
125.3
1392
2332
Nostoc flagelliforme
species
0.002
0.27
122.8
316
84
Geobacillus
genus
0.003
0.43
122.4
672
291
Bacteroides heparinolyticus
species
0.003
0.49
122.1
928
454
Erysipelothrix muris
species
0.014
0.59
121.6
2029
1195
Pelagicoccus croceus
species
0.002
0.32
120.7
380
120
Deferribacter autotrophicus
species
0.002
0.31
120.3
374
117
Deferribacter
genus
0.002
0.32
119.9
377
119
Psychroflexus
genus
0.002
0.3
117.5
348
105
Summary
A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.
A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.
Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.
Probiotics Suggestions
The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.
Good Count: Number of bacteria expected to shift in desired direction
Bad Count: Number of bacteria expected to shift in wrong direction
Impact: Estimator of impact based on Chi-2, Slope and R2 vectors
This document presents the results of statistical analysis on symptoms from viable, self-annotated Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?.
Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).
The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale.
Significance
Genus
p < 0.01
202
p < 0.001
173
p < 0.0001
145
p < 0.00001
129
Averages and Medians
I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at Bacteroides uniformis below, we see that the average is above and the median below.
If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports).
tax_name
Rank
Symptom Avarage
Reference Average
Symptom Median
Reference Median
Bacteroides
genus
27.633
25.884
24.121
26.729
Bacteroides uniformis
species
2.985
2.705
1.527
2.059
Novispirillum
genus
0.784
0.876
0.085
0.174
Insolitispirillum
genus
0.784
0.877
0.086
0.174
Insolitispirillum peregrinum
species
0.784
0.877
0.086
0.174
Bacteroides cellulosilyticus
species
1.024
0.836
0.073
0.151
Bilophila
genus
0.376
0.348
0.206
0.265
Bifidobacterium
genus
0.607
0.969
0.131
0.072
Bilophila wadsworthia
species
0.365
0.339
0.196
0.255
Blautia obeum
species
0.654
0.563
0.228
0.281
Hathewaya histolytica
species
0.318
0.275
0.154
0.188
Hathewaya
genus
0.318
0.275
0.154
0.188
Lachnobacterium
genus
0.327
0.32
0.075
0.049
Anaerotruncus
genus
0.213
0.184
0.136
0.159
Bifidobacterium longum
species
0.248
0.33
0.05
0.029
Oribacterium
genus
0.123
0.131
0.074
0.053
Anaerotruncus colihominis
species
0.2
0.173
0.133
0.153
Oribacterium sinus
species
0.116
0.127
0.072
0.053
Odoribacter
genus
0.194
0.197
0.123
0.139
Megamonas
genus
0.42
0.439
0.003
0.018
Bacteria Incidence – How often is it reported
The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing. Look at Bacteroides uniformis below, we see that the average is above and the median below
tax_name
Rank
Incidence Odds Ratio
Chi2
Symptoms %
Reference %
Prevotella bivia
species
1.42
9.5
26.9
19
More or Less often based on Symptom Median All Incidence
This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.
tax_name
Rank
Symptom Median
Odds Ratio
Chi2
Below
Above
Alcanivorax
genus
0.002
0.27
77.8
360
99
Isoalcanivorax
genus
0.002
0.27
77.3
349
95
Isoalcanivorax indicus
species
0.002
0.27
77.3
349
95
Niabella aurantiaca
species
0.002
0.34
69.1
505
172
Psychroflexus
genus
0.002
0.3
66.9
345
105
Psychroflexus gondwanensis
species
0.002
0.3
66.9
345
105
Salidesulfovibrio
genus
0.002
0.32
65.7
376
120
Salidesulfovibrio brasiliensis
species
0.002
0.32
65.7
376
120
Deferribacter autotrophicus
species
0.002
0.32
65.4
366
116
Deferribacter
genus
0.002
0.32
64.5
368
118
Psychrobacter glacialis
species
0.002
0.38
62.5
623
237
Pelagicoccus croceus
species
0.002
0.32
62.3
357
116
Rickettsia marmionii Stenos et al. 2005
species
0.002
0.34
60.6
372
125
Bacillus ferrariarum
species
0.002
0.34
58.4
350
118
Niabella
genus
0.002
0.39
56.6
542
211
Actinopolyspora
genus
0.002
0.39
55.8
505
195
Chromatium
genus
0.002
0.39
54.7
480
185
Chromatium weissei
species
0.002
0.39
54.4
479
185
Viridibacillus neidei
species
0.002
0.38
53.7
445
170
Segetibacter aerophilus
species
0.002
0.36
53.7
353
126
More or Less often based on Reference Median All Incidence
This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.
tax_name
Rank
Reference Median
Odds Ratio
Chi2
Below
Above
Methylobacillus glycogenes
species
0.003
0.4
217.9
1190
477
Methylobacillus
genus
0.003
0.42
203.2
1190
496
Psychrobacter glacialis
species
0.002
0.38
143.2
623
237
Niabella aurantiaca
species
0.002
0.34
140.5
505
172
Alcanivorax
genus
0.002
0.27
133.4
360
99
Isoalcanivorax
genus
0.002
0.27
131
349
95
Isoalcanivorax indicus
species
0.002
0.27
131
349
95
Niabella
genus
0.002
0.39
122.8
542
211
Salidesulfovibrio
genus
0.002
0.32
117.8
376
120
Salidesulfovibrio brasiliensis
species
0.002
0.32
117.8
376
120
Actinopolyspora
genus
0.002
0.39
117.1
505
195
Deferribacter autotrophicus
species
0.002
0.32
115.9
366
116
Psychroflexus
genus
0.002
0.3
115.2
345
105
Psychroflexus gondwanensis
species
0.002
0.3
115.2
345
105
Deferribacter
genus
0.002
0.32
114.9
368
118
Chromatium
genus
0.002
0.39
112.4
480
185
Chromatium weissei
species
0.002
0.39
111.9
479
185
Helicobacter suncus
species
0.002
0.46
111.6
717
333
Pelagicoccus croceus
species
0.002
0.32
110
357
116
Rickettsia marmionii Stenos et al. 2005
species
0.002
0.34
109.4
372
125
More or Less often based on Symptom Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
tax_name
Rank
Symptom Median Freq
Odds Ratio
Chi2
Below
Above
Clostridium taeniosporum
species
0.003
0.61
21
1269
777
Dethiosulfovibrio
genus
0.004
0.67
14.6
1417
946
Tetragenococcus doogicus
species
0.003
0.68
12.6
1279
876
Hydrocarboniphaga daqingensis
species
0.004
0.72
9.8
1499
1078
Mycoplasmopsis
genus
0.005
0.72
9.7
1661
1199
Pediococcus
genus
0.004
0.75
7.2
1217
913
Propionispora hippei
species
0.005
0.76
6.8
1449
1101
Propionispora
genus
0.005
0.76
6.7
1448
1102
More or Less often based on Reference Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
Methylobacillus glycogenes
species
0.003
0.4
217.9
1190
477
Methylobacillus
genus
0.003
0.42
203.2
1190
496
Psychrobacter glacialis
species
0.002
0.38
143.2
623
237
Niabella aurantiaca
species
0.002
0.34
140.5
505
172
Alcanivorax
genus
0.002
0.27
133.4
360
99
Isoalcanivorax
genus
0.002
0.27
131
349
95
Isoalcanivorax indicus
species
0.002
0.27
131
349
95
Niabella
genus
0.002
0.39
122.8
542
211
Salidesulfovibrio
genus
0.002
0.32
117.8
376
120
Salidesulfovibrio brasiliensis
species
0.002
0.32
117.8
376
120
Actinopolyspora
genus
0.002
0.39
117.1
505
195
Deferribacter autotrophicus
species
0.002
0.32
115.9
366
116
Psychroflexus
genus
0.002
0.3
115.2
345
105
Psychroflexus gondwanensis
species
0.002
0.3
115.2
345
105
Deferribacter
genus
0.002
0.32
114.9
368
118
Chromatium
genus
0.002
0.39
112.4
480
185
Chromatium weissei
species
0.002
0.39
111.9
479
185
Helicobacter suncus
species
0.002
0.46
111.6
717
333
Pelagicoccus croceus
species
0.002
0.32
110
357
116
Rickettsia marmionii Stenos et al. 2005
species
0.002
0.34
109.4
372
125
Summary
A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.
A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.
Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.
Probiotics Suggestions
The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.
Good Count: Number of bacteria expected to shift in desired direction
Bad Count: Number of bacteria expected to shift in wrong direction
Impact: Estimator of impact based on Chi-2, Slope and R2 vectors
This document presents the results of statistical analysis on symptoms from viable, self-annotated Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?.
Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).
The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale.
Significance
Genus
p < 0.01
182
p < 0.001
164
p < 0.0001
146
p < 0.00001
130
Averages and Medians
I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at the bacterua below, we see that for some the average is above and the median below. Should one increase or decrease this bacteria?
If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports). IMHO using average value instead of median will often result in a worse situation for the patient
tax_name
Rank
Symptom Avarage
Reference Average
Symptom Median
Reference Median
Bacteroides
genus
31.102
25.834
24.217
30.409
Faecalibacterium
genus
10.531
12.875
12.155
9.178
Faecalibacterium prausnitzii
species
10.193
12.301
11.47
8.958
Phocaeicola vulgatus
species
6.283
5.788
3.427
4.247
Bacteroides uniformis
species
3.229
2.71
1.559
2.11
Ruminococcus
genus
5.96
5.586
4.394
3.874
Coprococcus
genus
1.313
1.436
0.738
0.483
Clostridium
genus
2.067
1.85
1.359
1.612
Phocaeicola dorei
species
3.715
2.873
0.412
0.196
Bacteroides thetaiotaomicron
species
1.612
1.049
0.463
0.593
Bacteroides cellulosilyticus
species
1.092
0.844
0.075
0.179
Lachnospira pectinoschiza
species
0.549
0.668
0.337
0.245
Ruminococcus bromii
species
0.784
0.791
0.174
0.083
Bifidobacterium
genus
0.574
0.95
0.128
0.045
Bilophila wadsworthia
species
0.387
0.34
0.199
0.273
Bilophila
genus
0.395
0.348
0.209
0.281
Lachnobacterium
genus
0.222
0.325
0.076
0.028
Sutterella wadsworthensis
species
0.711
0.657
0.059
0.011
Dorea
genus
0.494
0.482
0.292
0.336
Hathewaya
genus
0.381
0.275
0.155
0.198
Bacteria Incidence – How often is it reported
The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing.
tax_name
Rank
Incidence Odds Ratio
Chi2
Symptoms %
Reference %
Halanaerobium
genus
1.58
7.7
26.4
16.7
More or Less often based on Symptom Median All Incidence
This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.
tax_name
Rank
Symptom Median
Odds Ratio
Chi2
Below
Above
Isoalcanivorax
genus
0.002
0.26
53.9
371
98
Isoalcanivorax indicus
species
0.002
0.26
53.9
371
98
Alcanivorax
genus
0.002
0.27
53.8
382
102
Niabella aurantiaca
species
0.002
0.33
43.2
545
182
Pelagicoccus croceus
species
0.002
0.32
40.7
378
122
Psychrobacter glacialis
species
0.002
0.38
35.8
660
250
Niabella
genus
0.002
0.38
35
585
221
Viridibacillus neidei
species
0.002
0.38
32.9
472
179
Chromatium
genus
0.002
0.39
32.1
515
200
Chromatium weissei
species
0.002
0.39
32
514
200
Sporosarcina pasteurii
species
0.002
0.4
28.6
444
179
Thiorhodococcus
genus
0.002
0.42
27.4
578
245
Syntrophomonas sapovorans
species
0.002
0.42
27
536
227
Sporosarcina
genus
0.002
0.42
26.9
448
186
Lysinibacillus
genus
0.002
0.42
25.9
401
167
Thermodesulfovibrio thiophilus
species
0.002
0.45
23.5
540
243
Oenococcus
genus
0.002
0.46
22.6
601
277
Thermodesulfovibrio
genus
0.002
0.47
22.1
625
292
Helicobacter suncus
species
0.002
0.48
21.7
761
363
Viridibacillus
genus
0.002
0.5
17.6
486
242
More or Less often based on Reference Median All Incidence
This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.
tax_name
Rank
Reference Median
Odds Ratio
Chi2
Below
Above
Lachnobacterium
genus
0.028
2.07
243
1197
2474
Bifidobacterium longum
species
0.0135
2.14
228.2
900
1929
Paenibacillus
genus
0.003
0.38
208.1
999
384
Erysipelothrix
genus
0.017
0.51
205.7
2244
1135
Anaerobranca zavarzinii
species
0.005
1.98
195.5
1046
2066
Anaerobranca
genus
0.005
1.98
195.5
1046
2066
Erysipelothrix muris
species
0.016
0.52
191.4
2194
1135
Slackia
genus
0.009
1.9
182.1
1161
2202
Legionella shakespearei
species
0.003
0.37
158.9
659
243
Bacteroides
genus
30.409
0.57
158.2
2511
1422
Faecalibacterium
genus
9.178
1.76
157.2
1423
2508
Niabella aurantiaca
species
0.002
0.33
155.3
545
182
Eubacterium callanderi
species
0.007
0.54
155.2
1882
1016
Holdemania
genus
0.027
0.56
153.4
2222
1244
Psychrobacter glacialis
species
0.002
0.38
152.7
660
250
Bifidobacterium
genus
0.045
1.73
146.5
1413
2447
Methylonatrum
genus
0.004
0.54
142.5
1617
870
Methylonatrum kenyense
species
0.004
0.54
142.5
1617
870
Amedibacillus dolichus
species
0.022
0.54
141.7
1678
912
Amedibacillus
genus
0.022
0.54
141.4
1677
912
More or Less often based on Symptom Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
tax_name
Rank
Symptom Median Freq
Odds Ratio
Chi2
Below
Above
Clostridium taeniosporum
species
0.003
0.61
10.2
1349
827
Dethiosulfovibrio
genus
0.004
0.67
6.7
1505
1012
More or Less often based on Reference Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
tax_name
Rank
Reference Median Freq
Odds Ratio
Chi2
Below
Above
Lachnobacterium
genus
0.028
2.07
243
1197
2474
Bifidobacterium longum
species
0.0135
2.14
228.2
900
1929
Paenibacillus
genus
0.003
0.38
208.1
999
384
Erysipelothrix
genus
0.017
0.51
205.7
2244
1135
Anaerobranca zavarzinii
species
0.005
1.98
195.5
1046
2066
Anaerobranca
genus
0.005
1.98
195.5
1046
2066
Erysipelothrix muris
species
0.016
0.52
191.4
2194
1135
Slackia
genus
0.009
1.9
182.1
1161
2202
Legionella shakespearei
species
0.003
0.37
158.9
659
243
Bacteroides
genus
30.409
0.57
158.2
2511
1422
Faecalibacterium
genus
9.178
1.76
157.2
1423
2508
Niabella aurantiaca
species
0.002
0.33
155.3
545
182
Eubacterium callanderi
species
0.007
0.54
155.2
1882
1016
Holdemania
genus
0.027
0.56
153.4
2222
1244
Psychrobacter glacialis
species
0.002
0.38
152.7
660
250
Bifidobacterium
genus
0.045
1.73
146.5
1413
2447
Methylonatrum
genus
0.004
0.54
142.5
1617
870
Methylonatrum kenyense
species
0.004
0.54
142.5
1617
870
Amedibacillus dolichus
species
0.022
0.54
141.7
1678
912
Amedibacillus
genus
0.022
0.54
141.4
1677
912
Summary
A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.
A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.
Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.
Probiotics Suggestions
The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.
Good Count: Number of bacteria expected to shift in desired direction
Bad Count: Number of bacteria expected to shift in wrong direction
Impact: Estimator of impact based on Chi-2, Slope and R2 vectors
This document presents the results of statistical analysis on symptoms from viable, self-annotated Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?.
Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).
The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale.
Significance
Genus
p < 0.01
223
p < 0.001
199
p < 0.0001
181
p < 0.00001
164
Averages and Medians
I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at the bacterua below, we see that for some the average is above and the median below. Should one increase or decrease this bacteria?
If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports). IMHO using average value instead of median will often result in a worse situation for the patient
tax_name
Rank
Symptom Average
Reference Average
Symptom Median
Reference Median
Faecalibacterium prausnitzii
species
13.575
12.086
11.275
12.554
Phocaeicola dorei
species
3.484
2.854
0.395
0.746
Roseburia
genus
2.432
2.876
1.812
1.484
Lachnospira
genus
2.424
2.755
1.901
1.631
Roseburia faecis
species
0.855
1.239
0.594
0.378
Sutterella wadsworthensis
species
0.75
0.65
0.049
0.239
Coprococcus
genus
1.083
1.463
0.741
0.609
Pedobacter
genus
1.299
0.971
0.551
0.651
Blautia wexlerae
species
0.474
0.589
0.324
0.27
Anaeroplasma
genus
1.197
0.432
0.003
0.05
Dorea
genus
0.454
0.486
0.299
0.256
Parabacteroides goldsteinii
species
0.585
0.569
0.133
0.171
Thermicanus
genus
0.206
0.188
0.101
0.127
Odoribacter
genus
0.28
0.189
0.122
0.146
Bacteroides stercorirosoris
species
0.166
0.196
0.139
0.116
Collinsella aerofaciens
species
0.154
0.172
0.05
0.071
Acetivibrio alkalicellulosi
species
0.237
0.261
0.1
0.08
Acetivibrio
genus
0.246
0.27
0.105
0.085
Dorea formicigenerans
species
0.111
0.136
0.086
0.067
Anaerofilum
genus
0.23
0.273
0.109
0.092
Bacteria Incidence – How often is it reported
The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing.
tax_name
Rank
Incidence Odds Ratio
Chi2
Symptoms %
Reference %
Lactococcus
genus
1.27
7.2
60.5
47.6
Sporotomaculum
genus
0.72
8.8
31.6
43.8
Sporotomaculum syntrophicum
species
0.73
8.5
31.3
43.2
Enterobacter hormaechei
species
0.7
6.9
18
25.8
Actinopolyspora
genus
0.58
9.9
10.6
18.2
Rothia mucilaginosa
species
0.62
8.3
11.7
18.8
Citrobacter
genus
0.65
7.1
12.5
19.2
Peptoniphilus lacrimalis
species
1.47
8.2
20.7
14.1
Chromatium
genus
0.63
7.3
11.2
17.6
Chromatium weissei
species
0.64
7.3
11.2
17.6
Anaerococcus hydrogenalis
species
1.48
6.9
16.1
10.9
More or Less often based on Symptom Median All Incidence
This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.
tax_name
Rank
Symptom Median
Odds Ratio
Chi2
Below
Above
Isoalcanivorax
genus
0.002
0.27
76.7
370
99
Isoalcanivorax indicus
species
0.002
0.27
76.7
370
99
Alcanivorax
genus
0.002
0.27
76.6
380
103
Nostoc flagelliforme
species
0.002
0.25
74.8
311
78
Niabella aurantiaca
species
0.002
0.32
71.5
534
172
Pelagicoccus croceus
species
0.002
0.3
66
378
115
Psychrobacter glacialis
species
0.002
0.36
65.8
654
233
Deferribacter autotrophicus
species
0.002
0.31
65.2
378
116
Deferribacter
genus
0.002
0.31
64.6
381
118
Salidesulfovibrio
genus
0.002
0.32
63.2
386
122
Salidesulfovibrio brasiliensis
species
0.002
0.32
63.2
386
122
Actinopolyspora
genus
0.002
0.36
60.6
537
192
Niabella
genus
0.002
0.36
60.1
571
208
Rickettsia marmionii Stenos et al. 2005
species
0.002
0.33
60
394
130
Lentibacillus
genus
0.002
0.36
57.6
500
181
Psychroflexus
genus
0.002
0.32
57.5
343
111
Psychroflexus gondwanensis
species
0.002
0.32
57.5
343
111
Lentibacillus salinarum
species
0.002
0.36
57.2
485
175
Viridibacillus neidei
species
0.002
0.36
56.6
463
166
Bacillus ferrariarum
species
0.002
0.34
56.1
361
121
More or Less often based on Reference Median All Incidence
This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.
tax_name
Rank
Reference Median
Odds Ratio
Chi2
Below
Above
Actinopolyspora
genus
0.003
0.16
326.3
628
101
Nostoc
genus
0.003
0.33
281.5
1134
376
Flammeovirga
genus
0.003
0.35
186.1
742
261
Asticcacaulis
genus
0.003
0.42
185.9
1064
446
Flammeovirga pacifica
species
0.003
0.35
185.6
741
261
Planococcus
genus
0.003
0.32
182.4
613
194
Planococcus columbae
species
0.003
0.31
176.2
575
179
Streptococcus oralis
species
0.003
0.48
167.3
1358
652
Psychrobacter glacialis
species
0.002
0.36
164.8
654
233
Niabella aurantiaca
species
0.002
0.32
158.7
534
172
Clostridium tepidiprofundi
species
0.003
0.38
152.9
659
248
Niabella
genus
0.002
0.36
142.4
571
208
Alcanivorax
genus
0.002
0.27
142.3
380
103
Isoalcanivorax
genus
0.002
0.27
140.7
370
99
Isoalcanivorax indicus
species
0.002
0.27
140.7
370
99
Atopobium fossor
species
0.003
0.37
138.2
555
203
Lentibacillus
genus
0.002
0.36
128.3
500
181
Nostoc flagelliforme
species
0.002
0.25
127.5
311
78
Desulfitobacterium
genus
0.005
0.38
126.8
525
197
Lentibacillus salinarum
species
0.002
0.36
125.5
485
175
More or Less often based on Symptom Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
tax_name
Rank
Symptom Median Freq
Odds Ratio
Chi2
Below
Above
Clostridium taeniosporum
species
0.003
0.62
17.5
1284
800
Dethiosulfovibrio
genus
0.004
0.67
12.7
1433
961
Tetragenococcus doogicus
species
0.003
0.68
11.8
1289
875
Mycoplasmopsis
genus
0.005
0.7
10
1707
1203
Hydrocarboniphaga daqingensis
species
0.004
0.72
9
1533
1097
Tetragenococcus
genus
0.003
0.74
6.8
1270
946
Pediococcus
genus
0.004
0.75
6.6
1239
926
More or Less often based on Reference Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
tax_name
Rank
Reference Median Freq
Odds Ratio
Chi2
Below
Above
Actinopolyspora
genus
0.003
0.16
326.3
628
101
Nostoc
genus
0.003
0.33
281.5
1134
376
Flammeovirga
genus
0.003
0.35
186.1
742
261
Asticcacaulis
genus
0.003
0.42
185.9
1064
446
Flammeovirga pacifica
species
0.003
0.35
185.6
741
261
Planococcus
genus
0.003
0.32
182.4
613
194
Planococcus columbae
species
0.003
0.31
176.2
575
179
Streptococcus oralis
species
0.003
0.48
167.3
1358
652
Psychrobacter glacialis
species
0.002
0.36
164.8
654
233
Niabella aurantiaca
species
0.002
0.32
158.7
534
172
Clostridium tepidiprofundi
species
0.003
0.38
152.9
659
248
Niabella
genus
0.002
0.36
142.4
571
208
Alcanivorax
genus
0.002
0.27
142.3
380
103
Isoalcanivorax
genus
0.002
0.27
140.7
370
99
Isoalcanivorax indicus
species
0.002
0.27
140.7
370
99
Atopobium fossor
species
0.003
0.37
138.2
555
203
Lentibacillus
genus
0.002
0.36
128.3
500
181
Nostoc flagelliforme
species
0.002
0.25
127.5
311
78
Desulfitobacterium
genus
0.005
0.38
126.8
525
197
Lentibacillus salinarum
species
0.002
0.36
125.5
485
175
Summary
A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.
A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.
Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.
Probiotics Suggestions
The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.
Good Count: Number of bacteria expected to shift in desired direction
Bad Count: Number of bacteria expected to shift in wrong direction
Impact: Estimator of impact based on Chi-2, Slope and R2 vectors
Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?. Self-described: Official Diagnosis: Mast Cell Dysfunction
Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).
The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale.
Significance
Genus
p < 0.01
131
p < 0.001
118
p < 0.0001
106
p < 0.00001
94
Averages and Medians
I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at the bacterua below, we see that for some the average is above and the median below. Should one increase or decrease this bacteria?
If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports). IMHO using average value instead of median will often result in a worse situation for the patient
tax_name
Rank
Symptom Avarage
Reference Average
Symptom Median
Reference Median
Phocaeicola dorei
species
4.464
2.872
0.399
0.92
Roseburia
genus
3.065
2.833
1.786
2.058
Sutterella
genus
1.711
1.643
1.259
1.022
Parabacteroides merdae
species
0.558
0.75
0.306
0.09
Clostridium
genus
1.977
1.856
1.363
1.566
Bacteroides thetaiotaomicron
species
1.754
1.057
0.464
0.659
Coprococcus
genus
1.271
1.435
0.73
0.597
Mediterraneibacter
genus
1.174
0.706
0.279
0.386
Bacteroides caccae
species
1.451
0.864
0.29
0.19
Bacteroides cellulosilyticus
species
1.26
0.845
0.076
0.158
Lachnospira pectinoschiza
species
0.67
0.663
0.334
0.257
Blautia obeum
species
0.593
0.572
0.233
0.303
Bilophila
genus
0.363
0.35
0.211
0.272
Hathewaya histolytica
species
0.426
0.275
0.156
0.205
Hathewaya
genus
0.427
0.276
0.156
0.205
Sutterella wadsworthensis
species
0.845
0.655
0.058
0.011
Veillonella criceti
species
0.279
0.237
0.124
0.168
Bacteroides rodentium
species
0.338
0.393
0.187
0.231
Akkermansia
genus
1.582
1.353
0.053
0.011
Akkermansia muciniphila
species
1.582
1.354
0.053
0.011
Bacteria Incidence – How often is it reported
The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing.
Nothing found that was significant
More or Less often based on Symptom Median All Incidence
This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.
tax_name
Rank
Symptom Median
Odds Ratio
Chi2
Below
Above
Sulfobacillus acidophilus
species
0.002
0.39
10.8
84
33
Sulfobacillus
genus
0.002
0.39
10.8
84
33
Caldanaerobacter hydrothermalis
species
0.002
0.43
9.8
96
41
Caldanaerobacter
genus
0.002
0.43
9.8
96
41
Desulfotomaculum defluvii
species
0.003
0.56
8.1
1032
578
Pelagicoccus
genus
0.002
0.57
7.4
859
490
Alkalibacterium
genus
0.003
0.57
7.4
907
518
Hydrogenophilus
genus
0.003
0.58
7.3
1162
670
Sporotomaculum syntrophicum
species
0.003
0.59
6.8
1138
668
More or Less often based on Reference Median All Incidence
This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.
tax_name
Rank
Reference Median
Odds Ratio
Chi2
Below
Above
Nostoc
genus
0.003
0.34
295.7
1214
408
Bacillus
genus
0.006
0.43
277.1
1954
837
Erysipelothrix
genus
0.018
0.47
250.1
2346
1111
Psychrobacter
genus
0.003
0.39
239.8
1254
492
Sharpea
genus
0.025
0.4
233
1278
514
Methylobacillus glycogenes
species
0.003
0.4
232.7
1286
519
Sharpea azabuensis
species
0.025
0.41
226.8
1264
514
Methylobacillus
genus
0.003
0.42
219.3
1287
537
Erysipelothrix muris
species
0.017
0.5
218.7
2274
1130
Candidatus Tammella caduceiae
species
0.003
0.41
205.7
1155
478
Paenibacillus
genus
0.003
0.39
205.3
1016
398
Candidatus Tammella
genus
0.003
0.42
200.1
1170
494
[Ruminococcus] torques
species
0.04
0.51
189.3
1921
971
Holdemania
genus
0.028
0.53
187
2315
1225
Streptococcus oralis
species
0.003
0.47
185.8
1453
686
Amedibacillus dolichus
species
0.024
0.5
184.4
1759
879
Amedibacillus
genus
0.024
0.5
184
1758
879
Haemophilus parainfluenzae
species
0.01
1.91
173.7
1023
1952
Haemophilus
genus
0.01
1.89
170.3
1035
1959
Luteolibacter
genus
0.015
0.46
169.7
1177
541
More or Less often based on Symptom Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
Nothing found that was significant
More or Less often based on Reference Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
tax_name
Rank
Reference Median Freq
Odds Ratio
Chi2
Below
Above
Nostoc
genus
0.003
0.34
295.7
1214
408
Bacillus
genus
0.006
0.43
277.1
1954
837
Erysipelothrix
genus
0.018
0.47
250.1
2346
1111
Psychrobacter
genus
0.003
0.39
239.8
1254
492
Sharpea
genus
0.025
0.4
233
1278
514
Methylobacillus glycogenes
species
0.003
0.4
232.7
1286
519
Sharpea azabuensis
species
0.025
0.41
226.8
1264
514
Methylobacillus
genus
0.003
0.42
219.3
1287
537
Erysipelothrix muris
species
0.017
0.5
218.7
2274
1130
Candidatus Tammella caduceiae
species
0.003
0.41
205.7
1155
478
Paenibacillus
genus
0.003
0.39
205.3
1016
398
Candidatus Tammella
genus
0.003
0.42
200.1
1170
494
[Ruminococcus] torques
species
0.04
0.51
189.3
1921
971
Holdemania
genus
0.028
0.53
187
2315
1225
Streptococcus oralis
species
0.003
0.47
185.8
1453
686
Amedibacillus dolichus
species
0.024
0.5
184.4
1759
879
Amedibacillus
genus
0.024
0.5
184
1758
879
Haemophilus parainfluenzae
species
0.01
1.91
173.7
1023
1952
Haemophilus
genus
0.01
1.89
170.3
1035
1959
Luteolibacter
genus
0.015
0.46
169.7
1177
541
Summary
A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.
A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.
Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.
Probiotics Suggestions
The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.
Good Count: Number of bacteria expected to shift in desired direction
Bad Count: Number of bacteria expected to shift in wrong direction
Impact: Estimator of impact based on Chi-2, Slope and R2 vectors
Probiotic Species
Impact
Good Count
Bad Count
Akkermansia muciniphila
36.08
18
6
Segatella copri
32.72
5
2
Bifidobacterium breve
21.31
8
5
Bifidobacterium longum
19.06
8
6
Bifidobacterium adolescentis
14.38
8
7
Lactobacillus helveticus
9.11
48
27
Streptococcus thermophilus
7.97
8
2
Lactobacillus johnsonii
7.28
22
26
Bifidobacterium bifidum
4.35
7
2
Bifidobacterium catenulatum
4.24
8
0
Parabacteroides goldsteinii
4.11
5
9
Bifidobacterium animalis
1.97
7
0
Lactococcus lactis
1.1
6
2
Veillonella atypica
1.02
11
3
Clostridium butyricum
0.97
7
9
Limosilactobacillus vaginalis
0.86
20
29
Odoribacter laneus
0.76
2
0
Enterococcus durans
0.7
11
20
Limosilactobacillus fermentum
0.11
2
15
Leuconostoc mesenteroides
-0.07
3
7
Lacticaseibacillus paracasei
-0.07
2
9
Lacticaseibacillus rhamnosus
-0.09
0
2
Bifidobacterium pseudocatenulatum
-0.1
5
6
Heyndrickxia coagulans
-0.1
3
9
Ligilactobacillus salivarius
-0.14
1
6
Lactobacillus crispatus
-0.15
3
7
Lactiplantibacillus plantarum
-0.19
0
4
Lactiplantibacillus pentosus
-0.21
0
4
Lacticaseibacillus casei
-0.21
0
7
Lactobacillus acidophilus
-0.22
8
12
Bacillus subtilis
-0.26
8
27
Limosilactobacillus reuteri
-0.42
5
16
Lactobacillus jensenii
-1.41
15
29
Pediococcus acidilactici
-1.86
17
32
Enterococcus faecium
-2.58
7
22
Enterococcus faecalis
-9.41
28
50
Parabacteroides distasonis
-9.5
9
4
Blautia wexlerae
-13.3
1
3
Escherichia coli
-24.86
1
12
Blautia hansenii
-26.65
7
6
Faecalibacterium prausnitzii
-116.83
3
3
Bacteroides uniformis
-167.73
1
11
Bacteroides thetaiotaomicron
-178.11
1
11
Comments on this Condition
Two of the above sections reported nothing significant found. This implies that the microbiome plays a secondary role. The bacteria shifts are more likely consequences of the condition than triggers of the condition. Regardless, there is a potential that the above probiotics may modify the severity of the condition.
It is unclear if the shifts are due to anti-histamine and other drugs usage.
This document presents the results of statistical analysis on symptoms from viable, self-annotated Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?.
Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).
The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale.
Significance
Genus
p < 0.01
196
p < 0.001
172
p < 0.0001
154
p < 0.00001
140
Averages and Medians
I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at Bifidobacterium below, we see that the average is above and the median below.
If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports).
tax_name
Rank
Symptom Avarage
Reference Average
Symptom Median
Reference Median
Bacteroides
genus
28.802
25.926
24.224
27.059
Phocaeicola
genus
12.357
10.786
9.314
11.306
Phocaeicola vulgatus
species
7.043
5.751
3.394
4.929
Bacteroides uniformis
species
2.909
2.723
1.553
1.958
Bacteroides thetaiotaomicron
species
1.234
1.065
0.458
0.734
Coprococcus
genus
1.23
1.44
0.737
0.552
Roseburia faecis
species
0.969
1.217
0.577
0.455
Bilophila
genus
0.417
0.347
0.207
0.319
Bifidobacterium
genus
0.534
0.953
0.131
0.035
Bacteroides stercoris
species
2.066
1.543
0.033
0.123
Blautia coccoides
species
0.776
0.917
0.592
0.504
Bilophila wadsworthia
species
0.395
0.339
0.197
0.281
Mediterraneibacter
genus
0.885
0.708
0.278
0.326
Butyricimonas
genus
0.217
0.186
0.108
0.154
Hathewaya
genus
0.314
0.277
0.155
0.201
Hathewaya histolytica
species
0.314
0.277
0.155
0.201
Bacteroides rodentium
species
0.435
0.39
0.186
0.231
Bifidobacterium longum
species
0.237
0.326
0.051
0.012
Lachnobacterium
genus
0.197
0.327
0.075
0.041
Bacteroides stercorirosoris
species
0.234
0.191
0.135
0.164
Bacteria Incidence – How often is it reported
The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing. Look at Bacteroides uniformis below, we see that the average is above and the median below
tax_name
Rank
Incidence Odds Ratio
Chi2
Symptoms %
Reference %
Bifidobacterium breve
species
0.64
7.8
26.6
41.4
Anaerococcus hydrogenalis
species
1.66
7.2
18.2
11
More or Less often based on Symptom Median All Incidence
This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.
tax_name
Rank
Symptom Median
Odds Ratio
Chi2
Below
Above
Niabella aurantiaca
species
0.002
0.34
44.3
544
183
Psychroflexus
genus
0.002
0.31
43.7
357
111
Psychroflexus gondwanensis
species
0.002
0.31
43.7
357
111
Rickettsia marmionii Stenos et al. 2005
species
0.002
0.33
41.6
398
131
Psychrobacter glacialis
species
0.002
0.37
38.6
660
246
Niabella
genus
0.002
0.38
36
584
222
Chromatium
genus
0.002
0.38
34.4
517
198
Chromatium weissei
species
0.002
0.38
34.2
516
198
Lentibacillus
genus
0.002
0.38
34
510
196
Lentibacillus salinarum
species
0.002
0.38
33.7
494
190
Viridibacillus neidei
species
0.002
0.38
33.3
469
180
Thermoanaerobacterium
genus
0.002
0.41
30
483
196
Thiomicrospira
genus
0.002
0.39
29.3
335
130
Sporosarcina pasteurii
species
0.002
0.41
29.2
439
178
Thiorhodococcus
genus
0.002
0.42
29.1
578
243
Thermoanaerobacterium islandicum
species
0.002
0.41
29
476
196
Syntrophomonas sapovorans
species
0.002
0.42
29
534
223
Sporosarcina
genus
0.002
0.42
27.5
443
185
Thermodesulfovibrio thiophilus
species
0.002
0.44
25.5
536
237
Oenococcus
genus
0.002
0.45
24.8
604
273
More or Less often based on Reference Median All Incidence
This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.
tax_name
Rank
Reference Median
Odds Ratio
Chi2
Below
Above
Bifidobacterium longum
species
0.012
2.27
260.2
870
1971
Bifidobacterium
genus
0.035
2.04
241.7
1266
2586
Methylobacillus glycogenes
species
0.003
0.4
232.5
1250
497
Methylobacillus
genus
0.003
0.41
217.2
1249
516
Corynebacterium
genus
0.0085
0.42
201.9
1163
486
Bilophila
genus
0.3185
0.55
162.8
2247
1236
Erysipelothrix muris
species
0.015
0.55
161
2153
1179
Psychrobacter glacialis
species
0.002
0.37
156.5
660
246
Niabella aurantiaca
species
0.002
0.34
153.5
544
183
Methylonatrum
genus
0.004
0.53
145.2
1620
866
Methylonatrum kenyense
species
0.004
0.53
145.2
1620
866
Catonella morbi
species
0.01
0.56
144
1968
1099
Catonella
genus
0.01
0.56
141.4
1966
1104
Erysipelothrix
genus
0.0155
0.57
139.9
2151
1232
Niabella
genus
0.002
0.38
137
584
222
Megasphaera elsdenii
species
0.0045
0.41
132.7
640
260
Bacteroides thetaiotaomicron
species
0.734
0.6
130.1
2389
1422
Veillonella parvula
species
0.003
1.9
128.6
666
1266
Alkalithermobacter paradoxus
species
0.004
0.55
125.8
1537
853
Odoribacter denticanis
species
0.005
0.57
124.1
1642
928
More or Less often based on Symptom Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
tax_name
Rank
Symptom Median Freq
Odds Ratio
Chi2
Below
Above
Clostridium taeniosporum
species
0.003
0.61
11.2
1344
814
Dethiosulfovibrio
genus
0.004
0.66
7.6
1500
994
Tetragenococcus doogicus
species
0.003
0.67
7.2
1360
910
More or Less often based on Reference Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
tax_name
Rank
Reference Median Freq
Odds Ratio
Chi2
Below
Above
Bifidobacterium longum
species
0.012
2.27
260.2
870
1971
Bifidobacterium
genus
0.035
2.04
241.7
1266
2586
Methylobacillus glycogenes
species
0.003
0.4
232.5
1250
497
Methylobacillus
genus
0.003
0.41
217.2
1249
516
Corynebacterium
genus
0.0085
0.42
201.9
1163
486
Bilophila
genus
0.3185
0.55
162.8
2247
1236
Erysipelothrix muris
species
0.015
0.55
161
2153
1179
Psychrobacter glacialis
species
0.002
0.37
156.5
660
246
Niabella aurantiaca
species
0.002
0.34
153.5
544
183
Methylonatrum
genus
0.004
0.53
145.2
1620
866
Methylonatrum kenyense
species
0.004
0.53
145.2
1620
866
Catonella morbi
species
0.01
0.56
144
1968
1099
Catonella
genus
0.01
0.56
141.4
1966
1104
Erysipelothrix
genus
0.0155
0.57
139.9
2151
1232
Niabella
genus
0.002
0.38
137
584
222
Megasphaera elsdenii
species
0.0045
0.41
132.7
640
260
Bacteroides thetaiotaomicron
species
0.734
0.6
130.1
2389
1422
Veillonella parvula
species
0.003
1.9
128.6
666
1266
Alkalithermobacter paradoxus
species
0.004
0.55
125.8
1537
853
Odoribacter denticanis
species
0.005
0.57
124.1
1642
928
Summary
A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.
A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.
Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.
Probiotics Suggestions
The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.
Good Count: Number of bacteria expected to shift in desired direction
Bad Count: Number of bacteria expected to shift in wrong direction
Impact: Estimator of impact based on Chi-2, Slope and R2 vectors
Some literature suggesting that the model’s suggestions are reasonable:
Bifidobacterium breve Bif11 supplementation improves depression-related neurobehavioural and neuroinflammatory changes in the mouse. Neuropharmacology (Neuropharmacology ) Vol: 229 Issue: Pages: 109480 Pub: 2023 May 15 ePub: 2023 Mar 1 Authors Sushma G,Vaidya B,Sharma S,Devabattula G,Bishnoi M,Kondepudi KK,Sharma SS
Heat-sterilized Bifidobacterium breve prevents depression-like behavior and interleukin-1ß expression in mice exposed to chronic social defeat stress. Brain, behavior, and immunity (Brain Behav Immun ) Vol: Issue: Pages: Pub: 2021 May 29 ePub: 2021 May 29 Authors Kosuge A,Kunisawa K,Arai S,Sugawara Y,Shinohara K,Iida T,Wulaer B,Kawai T,Fujigaki H,Yamamoto Y,Saito K,Nabeshima T,Mouri A
Bifidobacterium breve BB05 alleviates depressive symptoms in mice via the AKT/mTOR pathway. Frontiers in nutrition (Front Nutr ) Vol: 12 Issue: Pages: 1529566 Pub: 2025 ePub: 2025 Jan 30 Authors Pan Y,Huang Q,Liang Y,Xie Y,Tan F,Long X
Lipid and Energy Metabolism of the Gut Microbiota Is Associated with the Response to Probiotic Bifidobacterium breve Strain for Anxiety and Depressive Symptoms in Schizophrenia. Journal of personalized medicine (J Pers Med ) Vol: 11 Issue: 10 Pages: Pub: 2021 Sep 30 ePub: 2021 Sep 30 Authors Yamamura R,Okubo R,Katsumata N,Odamaki T,Hashimoto N,Kusumi I,Xiao J,Matsuoka YJ
Towards a psychobiotic therapy for depression: Bifidobacterium breve CCFM1025 reverses chronic stress-induced depressive symptoms and gut microbial abnormalities in mice. Neurobiology of stress (Neurobiol Stress ) Vol: 12 Issue: Pages: 100216 Pub: 2020 May ePub: 2020 Mar 20 Authors Tian P,O’Riordan KJ,Lee YK,Wang G,Zhao J,Zhang H,Cryan JF,Chen W
This document presents the results of statistical analysis on symptoms from viable, self-annotated Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?.
Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).
The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale.
Significance
Genus
p < 0.01
149
p < 0.001
121
p < 0.0001
96
p < 0.00001
79
Averages and Medians
I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at Bacteroides uniformis below, we see that the average is above and the median below.
If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports).
tax_name
Rank
Symptom Avarage
Reference Average
Symptom Median
Reference Median
Bacteroides
genus
28.504
25.674
23.872
27.629
Bacteroides uniformis
species
3.078
2.678
1.51
1.977
Coprococcus
genus
1.258
1.458
0.75
0.539
Bifidobacterium
genus
0.677
0.974
0.135
0.064
Bacteroides cellulosilyticus
species
1.06
0.822
0.073
0.126
Bilophila
genus
0.397
0.343
0.206
0.252
Bilophila wadsworthia
species
0.385
0.335
0.196
0.239
Alkaliphilus
genus
0.251
0.299
0.07
0.041
Alkaliphilus crotonatoxidans
species
0.245
0.291
0.065
0.037
Collinsella
genus
0.146
0.188
0.058
0.036
Bifidobacterium longum
species
0.221
0.338
0.052
0.03
Bacteroides stercorirosoris
species
0.216
0.19
0.134
0.156
Collinsella aerofaciens
species
0.138
0.175
0.056
0.036
Caloramator mitchellensis
species
0.798
0.873
0.054
0.035
Anaerotruncus
genus
0.195
0.186
0.136
0.155
Bacteroides salyersiae
species
0.262
0.367
0.022
0.004
Bacteroides faecis
species
0.145
0.118
0.055
0.071
Anaerotruncus colihominis
species
0.184
0.174
0.133
0.147
Oxalobacter
genus
0.036
0.03
0.018
0.027
Luteibacter anthropi
species
0.051
0.08
0.016
0.009
Bacteria Incidence – How often is it reported
The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing. Look at Bacteroides uniformis below, we see that the average is above and the median below
tax_name
Rank
Incidence Odds Ratio
Chi2
Symptoms %
Reference %
Bifidobacterium scardovii
species
0.71
6.6
12.3
17.2
More or Less often based on Symptom Median All Incidence
This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.
tax_name
Rank
Symptom Median
Odds Ratio
Chi2
Below
Above
Niabella aurantiaca
species
0.002
0.34
79.6
484
165
Psychrobacter glacialis
species
0.002
0.37
78.5
594
218
Niabella
genus
0.002
0.39
66
516
201
Viridibacillus neidei
species
0.002
0.38
61.6
426
163
Actinopolyspora
genus
0.002
0.4
61.5
489
195
Chromatium
genus
0.002
0.4
61.4
473
187
Chromatium weissei
species
0.002
0.4
61.1
472
187
Lentibacillus
genus
0.002
0.4
58.9
459
184
Lentibacillus salinarum
species
0.002
0.41
56.7
444
180
Thermoanaerobacterium
genus
0.002
0.42
53.1
438
183
Thiorhodococcus
genus
0.002
0.44
53.1
524
229
Thermoanaerobacterium islandicum
species
0.002
0.42
51.3
432
183
Syntrophomonas sapovorans
species
0.002
0.44
50.8
482
211
Thermodesulfovibrio thiophilus
species
0.002
0.44
49.5
481
213
Thermodesulfovibrio
genus
0.002
0.47
46.8
552
258
Desulfofundulus
genus
0.002
0.45
46.7
449
201
Helicobacter suncus
species
0.002
0.49
46.3
669
325
Oenococcus
genus
0.002
0.47
45.1
529
249
Vagococcus penaei
species
0.003
0.49
36.1
427
211
Viridibacillus
genus
0.002
0.5
34.8
437
220
More or Less often based on Reference Median All Incidence
This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.
tax_name
Rank
Reference Median
Odds Ratio
Chi2
Below
Above
Psychrobacter glacialis
species
0.002
0.37
144.3
594
218
Niabella aurantiaca
species
0.002
0.34
134.5
484
165
Niabella
genus
0.002
0.39
116.9
516
201
Bacteroides heparinolyticus
species
0.003
0.49
111.1
858
423
Actinopolyspora
genus
0.002
0.4
107.5
489
195
Chromatium
genus
0.002
0.4
106
473
187
Chromatium weissei
species
0.002
0.4
105.4
472
187
Viridibacillus neidei
species
0.002
0.38
102
426
163
Lentibacillus
genus
0.002
0.4
100.9
459
184
Thiorhodococcus
genus
0.002
0.44
96.8
524
229
Lentibacillus salinarum
species
0.002
0.41
96.2
444
180
Helicobacter suncus
species
0.002
0.49
94.8
669
325
Thermoanaerobacterium
genus
0.002
0.42
90.2
438
183
Syntrophomonas sapovorans
species
0.002
0.44
89.9
482
211
Thermodesulfovibrio
genus
0.002
0.47
88.2
552
258
Thermodesulfovibrio thiophilus
species
0.002
0.44
87.8
481
213
Thermoanaerobacterium islandicum
species
0.002
0.42
87
432
183
Oenococcus
genus
0.002
0.47
83.9
529
249
Hydrogenophilus
genus
0.003
0.58
81.2
1019
589
Desulfofundulus
genus
0.002
0.45
81
449
201
More or Less often based on Symptom Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
tax_name
Rank
Symptom Median Freq
Odds Ratio
Chi2
Below
Above
Clostridium taeniosporum
species
0.003
0.62
24.8
1203
751
Dethiosulfovibrio
genus
0.004
0.68
17.5
1353
917
Tetragenococcus doogicus
species
0.003
0.69
15.8
1214
836
Hydrocarboniphaga daqingensis
species
0.004
0.71
13.8
1453
1032
Mycoplasmopsis
genus
0.005
0.72
13.3
1600
1147
Pediococcus
genus
0.004
0.76
8.7
1168
886
Propionispora
genus
0.005
0.77
7.9
1374
1060
Propionispora hippei
species
0.005
0.77
7.9
1374
1060
Tetragenococcus
genus
0.003
0.78
6.7
1186
931
More or Less often based on Reference Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
tax_name
Rank
Reference Median Freq
Odds Ratio
Chi2
Below
Above
Psychrobacter glacialis
species
0.002
0.37
144.3
594
218
Niabella aurantiaca
species
0.002
0.34
134.5
484
165
Niabella
genus
0.002
0.39
116.9
516
201
Bacteroides heparinolyticus
species
0.003
0.49
111.1
858
423
Actinopolyspora
genus
0.002
0.4
107.5
489
195
Chromatium
genus
0.002
0.4
106
473
187
Chromatium weissei
species
0.002
0.4
105.4
472
187
Viridibacillus neidei
species
0.002
0.38
102
426
163
Lentibacillus
genus
0.002
0.4
100.9
459
184
Thiorhodococcus
genus
0.002
0.44
96.8
524
229
Lentibacillus salinarum
species
0.002
0.41
96.2
444
180
Helicobacter suncus
species
0.002
0.49
94.8
669
325
Thermoanaerobacterium
genus
0.002
0.42
90.2
438
183
Syntrophomonas sapovorans
species
0.002
0.44
89.9
482
211
Thermodesulfovibrio
genus
0.002
0.47
88.2
552
258
Thermodesulfovibrio thiophilus
species
0.002
0.44
87.8
481
213
Thermoanaerobacterium islandicum
species
0.002
0.42
87
432
183
Oenococcus
genus
0.002
0.47
83.9
529
249
Hydrogenophilus
genus
0.003
0.58
81.2
1019
589
Desulfofundulus
genus
0.002
0.45
81
449
201
Summary
A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.
A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.
Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.
Probiotics Suggestions
The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.
Good Count: Number of bacteria expected to shift in desired direction
Bad Count: Number of bacteria expected to shift in wrong direction
Impact: Estimator of impact based on Chi-2, Slope and R2 vectors
This document presents the results of statistical analysis on symptoms from viable, self-annotated Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?.
Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).
The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale.
Significance
Genus
p < 0.01
135
p < 0.001
100
p < 0.0001
83
p < 0.00001
69
Averages and Medians
I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at Bacteroides uniformis below, we see that the average is above and the median below.
If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports).
tax_name
Rank
Symptom Avarage
Reference Average
Symptom Median
Reference Median
Bacteroides
genus
27.303
25.835
24.008
26.554
Bacteroides uniformis
species
3.026
2.68
1.498
2.016
Phocaeicola dorei
species
3.35
2.83
0.379
0.672
Coprococcus
genus
1.354
1.444
0.739
0.612
Bifidobacterium
genus
0.698
0.975
0.136
0.064
Bacteroides cellulosilyticus
species
0.883
0.849
0.07
0.138
Bilophila
genus
0.41
0.34
0.206
0.25
Bacteroides rodentium
species
0.416
0.387
0.179
0.221
Bilophila wadsworthia
species
0.4
0.331
0.197
0.235
Bifidobacterium longum
species
0.244
0.336
0.052
0.03
Anaerotruncus
genus
0.197
0.185
0.136
0.156
Anaerotruncus colihominis
species
0.187
0.173
0.132
0.15
Collinsella
genus
0.146
0.189
0.057
0.042
Collinsella aerofaciens
species
0.139
0.176
0.054
0.042
Anaerobranca zavarzinii
species
0.14
0.159
0.015
0.009
Anaerobranca
genus
0.14
0.159
0.015
0.009
Bifidobacterium adolescentis
species
0.281
0.305
0.013
0.007
Oxalobacter
genus
0.033
0.03
0.018
0.023
Bifidobacterium choerinum
species
0.037
0.052
0.012
0.007
Acholeplasma hippikon
species
0.051
0.042
0.006
0.01
Bacteria Incidence – How often is it reported
The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing. Look at Bacteroides uniformis below, we see that the average is above and the median below
tax_name
Rank
Incidence Odds Ratio
Chi2
Symptoms %
Reference %
Aggregatibacter
genus
0.75
7.4
18.5
24.7
Prevotella bivia
species
1.29
6.6
24.4
19
Bifidobacterium scardovii
species
0.71
7.1
12.4
17.3
More or Less often based on Symptom Median All Incidence
This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.
tax_name
Rank
Symptom Median
Odds Ratio
Chi2
Below
Above
Psychrobacter glacialis
species
0.002
0.37
81
584
215
Chromatium
genus
0.002
0.38
69.5
466
175
Chromatium weissei
species
0.002
0.38
69.2
465
175
Niabella
genus
0.002
0.4
65.2
500
199
Actinopolyspora
genus
0.002
0.4
64.4
482
191
Thiorhodococcus
genus
0.002
0.43
57.4
516
221
Syntrophomonas sapovorans
species
0.002
0.43
55.9
477
203
Thermodesulfovibrio thiophilus
species
0.002
0.44
52.9
480
210
Thermodesulfovibrio
genus
0.002
0.46
50.9
554
255
Oenococcus
genus
0.002
0.46
50.7
528
241
Helicobacter suncus
species
0.002
0.49
46.3
656
324
Desulfofundulus
genus
0.002
0.47
41.9
434
206
Caldithrix
genus
0.002
0.52
36.7
541
282
Desulfotomaculum defluvii
species
0.003
0.56
36.2
906
508
Viridibacillus
genus
0.002
0.52
33.7
430
222
Streptococcus infantis
species
0.003
0.56
33.2
707
396
Sporotomaculum syntrophicum
species
0.003
0.58
32.4
996
582
Alkalibacterium
genus
0.003
0.58
31.6
792
456
Hydrogenophilus
genus
0.003
0.59
31.6
994
585
Pelagicoccus
genus
0.002
0.58
30.7
750
433
More or Less often based on Reference Median All Incidence
This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.
tax_name
Rank
Reference Median
Odds Ratio
Chi2
Below
Above
Psychrobacter glacialis
species
0.002
0.37
141.3
584
215
Bacteroides heparinolyticus
species
0.003
0.49
114
849
412
Chromatium
genus
0.002
0.38
113.2
466
175
Chromatium weissei
species
0.002
0.38
112.6
465
175
Odoribacter denticanis
species
0.005
0.56
110.5
1455
822
Niabella
genus
0.002
0.4
109.6
500
199
Actinopolyspora
genus
0.002
0.4
107
482
191
Thiorhodococcus
genus
0.002
0.43
99
516
221
Syntrophomonas sapovorans
species
0.002
0.43
93.7
477
203
Thermodesulfovibrio
genus
0.002
0.46
91.2
554
255
Helicobacter suncus
species
0.002
0.49
89.5
656
324
Thermodesulfovibrio thiophilus
species
0.002
0.44
89.5
480
210
Oenococcus
genus
0.002
0.46
89.2
528
241
Desulfotomaculum defluvii
species
0.003
0.56
81.7
906
508
Sporotomaculum syntrophicum
species
0.003
0.58
76.8
996
582
Hydrogenophilus
genus
0.003
0.59
74.9
994
585
Desulfosporosinus
genus
0.0025
1.67
71.5
600
1004
Clostridium taeniosporum
species
0.003
0.62
70.1
1184
734
Desulfofundulus
genus
0.002
0.47
69.5
434
206
Alkalibacterium
genus
0.003
0.58
68.1
792
456
More or Less often based on Symptom Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
tax_name
Rank
Symptom Median Freq
Odds Ratio
Chi2
Below
Above
Clostridium taeniosporum
species
0.003
0.62
27.2
1184
734
Mycoplasmopsis edwardii
species
0.005
0.67
21.1
1580
1053
Dethiosulfovibrio
genus
0.004
0.67
20
1335
893
Tetragenococcus doogicus
species
0.003
0.67
18.8
1206
813
Hydrocarboniphaga daqingensis
species
0.004
0.72
13.8
1422
1022
Mycoplasmopsis
genus
0.005
0.74
12
1550
1142
Pediococcus
genus
0.004
0.75
10
1141
855
Tetragenococcus
genus
0.003
0.76
9.2
1183
899
Propionispora hippei
species
0.005
0.77
8.5
1348
1039
Propionispora
genus
0.005
0.77
8.5
1348
1039
Phocaeicola coprocola
species
0.004
0.78
7.2
1068
836
Porphyromonas canis
species
0.005
0.8
6.6
1382
1100
More or Less often based on Reference Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
tax_name
Rank
Reference Median Freq
Odds Ratio
Chi2
Below
Above
Psychrobacter glacialis
species
0.002
0.37
141.3
584
215
Bacteroides heparinolyticus
species
0.003
0.49
114
849
412
Chromatium
genus
0.002
0.38
113.2
466
175
Chromatium weissei
species
0.002
0.38
112.6
465
175
Odoribacter denticanis
species
0.005
0.56
110.5
1455
822
Niabella
genus
0.002
0.4
109.6
500
199
Actinopolyspora
genus
0.002
0.4
107
482
191
Thiorhodococcus
genus
0.002
0.43
99
516
221
Syntrophomonas sapovorans
species
0.002
0.43
93.7
477
203
Thermodesulfovibrio
genus
0.002
0.46
91.2
554
255
Helicobacter suncus
species
0.002
0.49
89.5
656
324
Thermodesulfovibrio thiophilus
species
0.002
0.44
89.5
480
210
Oenococcus
genus
0.002
0.46
89.2
528
241
Desulfotomaculum defluvii
species
0.003
0.56
81.7
906
508
Sporotomaculum syntrophicum
species
0.003
0.58
76.8
996
582
Hydrogenophilus
genus
0.003
0.59
74.9
994
585
Desulfosporosinus
genus
0.0025
1.67
71.5
600
1004
Clostridium taeniosporum
species
0.003
0.62
70.1
1184
734
Desulfofundulus
genus
0.002
0.47
69.5
434
206
Alkalibacterium
genus
0.003
0.58
68.1
792
456
Summary
A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.
A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.
Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.
Probiotics Suggestions
The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.
Good Count: Number of bacteria expected to shift in desired direction
Bad Count: Number of bacteria expected to shift in wrong direction
Impact: Estimator of impact based on Chi-2, Slope and R2 vectors
Updated: Dec 3, 2025 correcting some computations errors.
This document presents the results of statistical analysis on symptoms from viable, self-annotated Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?.
Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).
The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale
Significance
Genus
p < 0.01
219
p < 0.001
189
p < 0.0001
161
p < 0.00001
143
Averages and Medians
I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at Bacteroides uniformis below, we see that the average is above and the median below.
If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports).
tax_name
Rank
Symptom Avarage
Reference Average
Symptom Median
Reference Median
Bacteroides
genus
29.336
25.739
23.905
29.302
Phocaeicola
genus
11.847
10.761
9.194
11.373
Phocaeicola vulgatus
species
6.735
5.719
3.351
4.42
Bacteroides uniformis
species
3.25
2.682
1.524
2.07
Coprococcus
genus
1.206
1.453
0.747
0.552
Bacteroides caccae
species
1.153
0.849
0.282
0.398
Pedobacter
genus
1.174
0.983
0.548
0.659
Bilophila
genus
0.425
0.343
0.203
0.309
Bilophila wadsworthia
species
0.412
0.335
0.193
0.29
Bifidobacterium
genus
0.653
0.961
0.132
0.055
Bacteroides rodentium
species
0.403
0.39
0.179
0.23
Sutterella wadsworthensis
species
0.642
0.66
0.059
0.012
Hathewaya
genus
0.35
0.272
0.153
0.191
Hathewaya histolytica
species
0.35
0.272
0.153
0.19
Phascolarctobacterium faecium
species
0.163
0.14
0.07
0.1
Lachnobacterium
genus
0.233
0.329
0.076
0.047
Butyricimonas
genus
0.194
0.186
0.107
0.133
Anaerofilum
genus
0.266
0.269
0.105
0.13
Oribacterium
genus
0.103
0.133
0.074
0.049
Anaerotruncus
genus
0.219
0.184
0.136
0.161
Bacteria Incidence – How often is it reported
The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing. Look at Bacteroides uniformis below, we see that the average is above and the median below.
tax_name
Rank
Incidence Odds Ratio
Chi2
Symptoms %
Reference %
Shewanella upenei
species
1.46
13
35.8
24.4
Methanobrevibacter
genus
0.61
10.4
13.8
22.4
Methanobrevibacter smithii
species
0.62
10.1
13.5
21.9
Slackia isoflavoniconvertens
species
0.62
9
12.7
20.4
Prosthecobacter
genus
1.68
12.9
17
10.1
Bifidobacterium cuniculi
species
0.66
7.1
12.7
19.4
Desulfomonile tiedjei
species
1.45
7.8
20.2
13.9
Desulfomonile
genus
1.44
7.6
20.2
14
More or Less often based on Symptom Median All Incidence
This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.
tax_name
Rank
Symptom Median
Odds Ratio
Chi2
Below
Above
Alcanivorax
genus
0.002
0.28
74.1
365
101
Isoalcanivorax
genus
0.002
0.28
73.2
355
98
Isoalcanivorax indicus
species
0.002
0.28
73.2
355
98
Nostoc flagelliforme
species
0.002
0.27
68.3
305
83
Pelagicoccus croceus
species
0.002
0.31
63.6
366
114
Psychroflexus
genus
0.002
0.31
63.1
348
107
Psychroflexus gondwanensis
species
0.002
0.31
63.1
348
107
Niabella aurantiaca
species
0.002
0.35
62.5
507
177
Salidesulfovibrio
genus
0.002
0.33
59.7
370
121
Salidesulfovibrio brasiliensis
species
0.002
0.33
59.7
370
121
Deferribacter autotrophicus
species
0.002
0.32
59.2
355
115
Psychrobacter glacialis
species
0.002
0.38
59.2
629
238
Deferribacter
genus
0.002
0.33
58.4
357
117
Bacillus ferrariarum
species
0.002
0.34
56
354
119
Rickettsia marmionii Stenos et al. 2005
species
0.002
0.36
52.7
374
133
Segetibacter aerophilus
species
0.002
0.35
51.8
356
126
Thiorhodococcus pfennigii
species
0.002
0.36
51.7
392
143
Niabella
genus
0.002
0.4
51.4
543
215
Pontibacillus halophilus
species
0.002
0.37
50.7
397
147
Pontibacillus
genus
0.002
0.37
50.6
401
149
More or Less often based on Reference Median All Incidence
This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.
tax_name
Rank
Reference Median
Odds Ratio
Chi2
Below
Above
Bilophila
genus
0.3095
0.55
154.4
2147
1184
Psychrobacter glacialis
species
0.002
0.38
145.8
629
238
Niabella aurantiaca
species
0.002
0.35
136.6
507
177
Alcanivorax
genus
0.002
0.28
134.4
365
101
Isoalcanivorax
genus
0.002
0.28
131.4
355
98
Isoalcanivorax indicus
species
0.002
0.28
131.4
355
98
Bilophila wadsworthia
species
0.2905
0.58
127.5
2096
1222
Bacteroides heparinolyticus
species
0.003
0.49
122
921
449
Niabella
genus
0.002
0.4
119.8
543
215
Pelagicoccus croceus
species
0.002
0.31
118.5
366
114
Nostoc flagelliforme
species
0.002
0.27
116.1
305
83
Psychroflexus
genus
0.002
0.31
114.9
348
107
Psychroflexus gondwanensis
species
0.002
0.31
114.9
348
107
Salidesulfovibrio
genus
0.002
0.33
112.8
370
121
Salidesulfovibrio brasiliensis
species
0.002
0.33
112.8
370
121
Actinopolyspora
genus
0.002
0.4
111.3
501
199
Chromatium
genus
0.002
0.39
111.3
491
193
Chromatium weissei
species
0.002
0.39
110.7
490
193
Bacteroides
genus
29.302
0.62
110.5
2318
1428
Thiorhodococcus
genus
0.002
0.42
110
551
231
More or Less often based on Symptom Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
tax_name
Rank
Symptom Median Freq
Odds Ratio
Chi2
Below
Above
Clostridium taeniosporum
species
0.003
0.61
19
1266
777
Dethiosulfovibrio
genus
0.004
0.68
12.3
1414
958
Tetragenococcus doogicus
species
0.003
0.69
11.3
1280
880
Hydrocarboniphaga daqingensis
species
0.004
0.7
10.4
1525
1069
Mycoplasmopsis
genus
0.005
0.71
10.2
1703
1201
Pediococcus
genus
0.004
0.75
6.6
1225
919
More or Less often based on Reference Median High Incidence
Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.
Bilophila
genus
0.3095
0.55
154.4
2147
1184
Psychrobacter glacialis
species
0.002
0.38
145.8
629
238
Niabella aurantiaca
species
0.002
0.35
136.6
507
177
Alcanivorax
genus
0.002
0.28
134.4
365
101
Isoalcanivorax indicus
species
0.002
0.28
131.4
355
98
Isoalcanivorax
genus
0.002
0.28
131.4
355
98
Bilophila wadsworthia
species
0.2905
0.58
127.5
2096
1222
Bacteroides heparinolyticus
species
0.003
0.49
122
921
449
Niabella
genus
0.002
0.4
119.8
543
215
Pelagicoccus croceus
species
0.002
0.31
118.5
366
114
Nostoc flagelliforme
species
0.002
0.27
116.1
305
83
Psychroflexus gondwanensis
species
0.002
0.31
114.9
348
107
Psychroflexus
genus
0.002
0.31
114.9
348
107
Salidesulfovibrio brasiliensis
species
0.002
0.33
112.8
370
121
Salidesulfovibrio
genus
0.002
0.33
112.8
370
121
Actinopolyspora
genus
0.002
0.4
111.3
501
199
Chromatium
genus
0.002
0.39
111.3
491
193
Chromatium weissei
species
0.002
0.39
110.7
490
193
Bacteroides
genus
29.302
0.62
110.5
2318
1428
Thiorhodococcus
genus
0.002
0.42
110
551
231
Summary
A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.
A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.
Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.
Probiotics Suggestions
The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.
Good Count: Number of bacteria expected to shift in desired direction
Bad Count: Number of bacteria expected to shift in wrong direction
Impact: Estimator of impact based on Chi-2, Slope and R2 vectors
Recent Comments